Individuals Discontinuing Anti-Obesity Injections Gain Back Pounds Far More Rapidly Compared to People Using Diet and Exercise

A recent study suggests that people who come off blockbuster weight-loss injections like Mounjaro or Wegovy may regain lost weight far faster than those who end conventional diet and exercise plans.

Research printed in a prominent health publication demonstrates that while obese individuals frequently drop a large proportion of their body weight while using the jabs, the weight comes back at an average rate of 0.8 kg per month after stopping.

"Individuals buying these treatments should be cognizant of the potential of rapid rebound weight gain when the medication ends," stated lead investigator Dr. Susan Jebb.

That rate of recovery suggests a return to original weight in about one and a half years.

Weighing Approaches

The study, which examined 37 of studies involving over 9,000 of participants, contrasted the results of GLP-1 agonists with other pills.

Scientists point out that individuals who shed pounds through lifestyle changes alone usually have a more gradual weight regain—approximately 0.1 kg a month—after stopping.

The Reason for the Fast Regain

Doctors propose the mechanism of the jabs accounts for the accelerated weight return.

These medications mimic a natural hormone called glucagon-like peptide-1, which controls feelings of fullness.

"Artificially providing GLP-1 levels far above than normal could lead to the body to produce less of its endogenous hormone, and may also reduce responsiveness to its effects," noted Dr. Adam Collins, a nutrition specialist.

"Withdrawal of this hormone supplement means hunger is no longer kept in check, making overeating much more probable."

A Chronic Condition?

Health authorities suggest the injections for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes.

Professionals argue that, due to the high risk of relapse, the therapy is often long-term.

This perspective is echoed by drug manufacturers, who note that the findings "highlight the long-term nature of obesity," comparing it to managing conditions like diabetes.

Patient Testimonies

Individuals who have come off the jabs report a intense return of cravings.

"It felt as if something activating and you become starving," recalled one woman.

This challenge is exacerbated if individuals have not adopted permanent lifestyle or habit changes during therapy.

Significant Use

Recent estimates show that a significant number of people in the UK have used these injections in the last 12 months, with desire continuing to grow.

• Adoption is more common among women than males.
• The middle-aged demographic shows the highest usage rates.
• Many access the medications through private healthcare rather than public health services.

Finally, researchers emphasize that while the jabs are powerful tools for shedding pounds, they are not a permanent solution and maintained weight loss relies on combined lifestyle changes.